These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 34387827

  • 1. Qishen Taohong Granule () as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure: A Randomized Controlled Trial.
    Li XX, Wu Y, Fan ZJ, Cui J, Li D, Lin Q, Zhuang R, Yan RK, Lin Q, Li Y.
    Chin J Integr Med; 2022 Jan; 28(1):12-19. PubMed ID: 34387827
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
    Wang J, Shi J, Wei J, Wang J, Gao K, Li X, Chen J, Li S, Zhao H, Wang W.
    Trials; 2017 Oct 10; 18(1):468. PubMed ID: 29017565
    [Abstract] [Full Text] [Related]

  • 3. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
    Li X, Zhang J, Huang J, Ma A, Yang J, Li W, Wu Z, Yao C, Zhang Y, Yao W, Zhang B, Gao R, Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group.
    J Am Coll Cardiol; 2013 Sep 17; 62(12):1065-1072. PubMed ID: 23747768
    [Abstract] [Full Text] [Related]

  • 4. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial.
    Wang X, Hu D, Dang S, Huang H, Huang CX, Yuan MJ, Tang YH, Zheng QS, Yin F, Zhang S, Zhang BL, Gao RL, Efficacy and Safety of Shensong Yangxin Capsules for Frequent VPCs in Congestive Heart Failure Study Group.
    Chin Med J (Engl); 2017 Jul 20; 130(14):1639-1647. PubMed ID: 28685712
    [Abstract] [Full Text] [Related]

  • 5. Effects of multifaceted optimization management for chronic heart failure: a multicentre, randomized controlled study.
    Pan G, Ji W, Wang X, Li S, Zheng C, Lyu W, Feng X, Xia Y, Xiong Z, Shan H, Yang H, Zou X.
    ESC Heart Fail; 2023 Feb 20; 10(1):133-147. PubMed ID: 36178015
    [Abstract] [Full Text] [Related]

  • 6. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 7. Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial.
    Yu M, Li S, Li S, Li J, Xu H, Chen K.
    Trials; 2018 Jul 16; 19(1):381. PubMed ID: 30012193
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial.
    Maulik SK, Wilson V, Seth S, Bhargava B, Dua P, Ramakrishnan S, Katiyar CK.
    Phytomedicine; 2016 Oct 15; 23(11):1211-9. PubMed ID: 26988798
    [Abstract] [Full Text] [Related]

  • 9. The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial.
    Du K, Liu J, Tan N, Huang X, Wang J, Zhao H, Wang W.
    Front Pharmacol; 2022 Oct 15; 13():1017734. PubMed ID: 36618925
    [Abstract] [Full Text] [Related]

  • 10. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
    Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP, TIME-CHF Investigators.
    JAMA; 2009 Jan 28; 301(4):383-92. PubMed ID: 19176440
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of Criterion Validity of CHF-Quality of Life Scale of Integrative Medicine].
    Wan J, Lin Q, Su JZ, Tan H, Li PH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Nov 28; 36(11):1300-1303. PubMed ID: 30641619
    [Abstract] [Full Text] [Related]

  • 12. Effects of trimetazidine in nonischemic heart failure: a randomized study.
    Winter JL, Castro PF, Quintana JC, Altamirano R, Enriquez A, Verdejo HE, Jalil JE, Mellado R, Concepción R, Sepúlveda P, Rossel V, Sepúlveda L, Chiong M, García L, Lavandero S.
    J Card Fail; 2014 Mar 28; 20(3):149-54. PubMed ID: 24412523
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of biventricular pacing on preventing heart failure in patients with high degree atrioventricular block (BIVPACE-AVB Trial)].
    Zhang XY, Shan QJ, Su YG, Yan J, Bao ZH, Gu X, Qiu JP, Qin SM, Xu J, Su H, Zhu H, Guo JF, Lu JP, Zou JG, Chen ML, Xu D, Cao KJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr 24; 44(4):331-7. PubMed ID: 27112612
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP, TIME-CHF Investigators.
    Circ Heart Fail; 2014 Jan 24; 7(1):131-9. PubMed ID: 24352403
    [Abstract] [Full Text] [Related]

  • 15. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
    Guo L, Yuan H, Zhang D, Zhang J, Hua Q, Ma X, Chen K.
    Medicine (Baltimore); 2020 May 22; 99(21):e20271. PubMed ID: 32481305
    [Abstract] [Full Text] [Related]

  • 16. Effect of yangxinkang tablets on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial.
    Xian SX, Yang ZQ, Ren PH, Ye XH, Ye SL, Wang QH, Wang ZH, Shen SJ, Huang XW.
    Chin J Integr Med; 2015 Oct 22; 21(10):733-42. PubMed ID: 25948124
    [Abstract] [Full Text] [Related]

  • 17. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
    Zhao XY, Yang YJ, Zhang J, Kang LM, Wei BQ, Gao XJ, Lü R, Zhang CL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun 22; 37(6):486-90. PubMed ID: 19927626
    [Abstract] [Full Text] [Related]

  • 18. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR, Lindenfeld J, Weaver FA, Zannad F, Galle E, Rogers T, Abraham WT.
    J Am Coll Cardiol; 2020 Jul 07; 76(1):1-13. PubMed ID: 32616150
    [Abstract] [Full Text] [Related]

  • 19. Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
    Qayyum AA, van Klarenbosch B, Frljak S, Cerar A, Poglajen G, Traxler-Weidenauer D, Nadrowski P, Paitazoglou C, Vrtovec B, Bergmann MW, Chamuleau SAJ, Wojakowski W, Gyöngyösi M, Kraaijeveld A, Hansen KS, Vrangbaek K, Jørgensen E, Helqvist S, Joshi FR, Johansen EM, Follin B, Juhl M, Højgaard LD, Mathiasen AB, Ekblond A, Haack-Sørensen M, Kastrup J, SCIENCE Investigators.
    Eur J Heart Fail; 2023 Apr 07; 25(4):576-587. PubMed ID: 36644821
    [Abstract] [Full Text] [Related]

  • 20. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP, TIME-CHF Investigators.
    Eur J Heart Fail; 2013 Oct 07; 15(10):1148-56. PubMed ID: 23657728
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.